Standardization and quality control of PCR analyses

Area of Science:

• Molecular Biology
• Medical Diagnostics
• Infectious Disease Research

Background:

• Early polymerase chain reaction (PCR) diagnostic tests for infectious agents were prone to false-positive results due to contamination.
• The implementation of uracil-N-glycosylase (UNG) technology has largely resolved contamination-related false positives in PCR.
• However, other sources of diagnostic errors, including human error, suboptimal protocols, and amplification of DNA from non-viable organisms, persist.

Purpose of the Study:

• To address the persistent challenges in achieving accurate PCR-based diagnosis of infectious agents.
• To highlight remaining sources of false-positive and false-negative results in PCR diagnostics.
• To review strategies for overcoming PCR inhibition and discuss quality control findings.

Main Methods:

• Review of anticontamination technologies, specifically uracil-N-glycosylase (UNG).
• Analysis of potential sources of false-positive results beyond contamination (human error, protocol deficiencies, amplification of dead organism DNA).
• Discussion of factors leading to false-negative PCR results, focusing on sample inhibition and interfering substances.

Main Results:

• UNG technology effectively mitigates contamination-induced false positives in PCR.
• False positives can still arise from human error, inadequate PCR protocols, and amplification of DNA from dead pathogens.
• False negatives are often caused by PCR inhibitors present in patient samples, alongside other protocol or human-related issues.

Conclusions:

• While UNG technology has improved PCR accuracy, careful attention to protocols and potential sources of error remains essential.
• Recognizing and mitigating sample inhibition is key to preventing false-negative PCR results.
• Quality control studies underscore the importance of robust amplification and detection methods for reliable infectious agent diagnosis.